Shannon Conley to Gene Transfer Techniques
This is a "connection" page, showing publications Shannon Conley has written about Gene Transfer Techniques.
Connection Strength
0.650
-
Non-viral therapeutic approaches to ocular diseases: An overview and future directions. J Control Release. 2015 Dec 10; 219:471-487.
Score: 0.126
-
Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases. J Control Release. 2013 Dec 28; 172(3):745-52.
Score: 0.109
-
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. Biomaterials. 2013 Sep; 34(29):7158-67.
Score: 0.108
-
Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One. 2012; 7(12):e52189.
Score: 0.104
-
Late-onset cone photoreceptor degeneration induced by R172W mutation in Rds and partial rescue by gene supplementation. Invest Ophthalmol Vis Sci. 2007 Dec; 48(12):5397-407.
Score: 0.073
-
Nanoparticle applications in ocular gene therapy. Vision Res. 2008 Feb; 48(3):319-24.
Score: 0.072
-
Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype. FASEB J. 2015 Jun; 29(6):2535-44.
Score: 0.030
-
Episomal maintenance of S/MAR-containing non-viral vectors for RPE-based diseases. Adv Exp Med Biol. 2014; 801:703-9.
Score: 0.028